(601530, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0004012', 'increased pulmonary artery pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601531, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0005645', 'abnormal hypothalamus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601532, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0003726', 'decreased autoantibody level', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601533, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0003034', 'increased pulmonary vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601534, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601535, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0011926', 'abnormal heart valve physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601536, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0030118', 'rhinosinusitis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(601537, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0004010', 'increased diastolic filling velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601538, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601539, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601540, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601541, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0012746', 'abnormal neural crest cell delamination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601542, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0004597', 'increased susceptibility to noise-induced hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601543, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0002626', 'increased heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601544, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0020220', 'decreased tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601545, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601546, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0020039', 'increased bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601547, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0002987', 'abnormal urine osmolality', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601548, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0002500', 'granulomatous inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601549, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0030939', 'abnormal autophagosome formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601550, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601551, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601552, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0003465', 'increased single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601553, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0020978', 'abnormal FO-wave implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601554, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0004213', 'abnormal umami taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601555, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601556, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0031497', 'increased visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601557, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601558, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008675', 'increased interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601559, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0005044', 'sepsis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601560, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008404', 'increased cellular sensitivity to methylmethanesulfonate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601561, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0013208', 'abnormal cilium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601562, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0001665', 'chronic diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601563, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0005647', 'abnormal sex gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601564, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0030940', 'impaired autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601565, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0031469', 'abnormal pinocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601566, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0000751', 'myopathy', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601567, 'HP:0002795', 'Abnormal respiratory system physiology', 'MP:0008706', 'decreased interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601568, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601569, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601570, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0002897', 'blotchy skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601571, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009607', 'decreased keratohyalin granule size', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601572, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009387', 'abnormal epidermal pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601573, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0005421', 'loose skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601574, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0011515', 'purpura', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601575, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601576, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003652', 'abnormal skin turgor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601577, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003853', 'dry skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601578, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001208', 'blistering', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601579, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001195', 'flaky skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601580, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001193', 'psoriasis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601581, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009827', 'skin detachment', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601582, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0002015', 'epithelioid cyst', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601583, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0011160', 'dermal-epidermal separation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601584, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003717', 'pallor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601585, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0010016', 'variable depigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601586, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009605', 'decreased keratohyalin granule number', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601587, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009604', 'increased keratohyalin granule number', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601588, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0002095', 'abnormal skin pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601589, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001191', 'abnormal skin condition', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601590, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601591, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001230', 'epidermal desquamation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601592, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001213', 'abnormal skin cell number', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601593, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008816', 'petechiae', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601594, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601595, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003196', 'calcified skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601596, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003940', 'abnormal dermatome morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601597, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009441', 'delayed skin barrier formation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601598, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009385', 'abnormal dermal pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601599, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001243', 'abnormal dermal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601600, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601601, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601602, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003941', 'abnormal skin development', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601603, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001201', 'translucent skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601604, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0013406', 'abnormal epidermal immune compartment', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601605, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0010232', 'delayed skin pigmentation appearance', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601606, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008854', 'bleb', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601607, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601608, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009563', 'dyskeratosis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601609, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009379', 'abnormal foot pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601610, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0003653', 'decreased skin turgor', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601611, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0002060', 'abnormal skin morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601612, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008856', 'fetal bleb', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601613, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001209', 'spontaneous skin ulceration', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601614, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601615, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0012078', 'abnormal tail ring morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601616, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601617, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601618, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009932', 'skin fibrosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601619, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001212', 'skin lesions', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601620, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0004241', 'acantholysis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601621, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0011239', 'abnormal skin coloration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601622, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601623, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001196', 'shiny skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601624, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009606', 'increased keratohyalin granule size', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601625, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001210', 'skin ridges', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601626, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001192', 'scaly skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601627, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0001198', 'tight skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601628, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0010206', 'pigment incontinence', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601629, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601630, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0031103', 'skin rash', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601631, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0009931', 'abnormal skin appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601632, 'HP:0007458', 'Focal hyperextensible skin', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(601633, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0009101', 'clitoris hypoplasia', 0.5, 15.607147267911275, 2.7934877185976026, 'UPHENO:0069241', 'decreased size of the clitoris'),
(601634, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0009100', 'abnormal clitoris size', 0.5102040816326531, 14.384754846574829, 2.7090885249484864, 'UPHENO:0075153', 'abnormal size of clitoris'),
(601635, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0009212', 'vulva atrophy', 0.46153846153846156, 11.684315128433736, 2.32223186364064, 'UPHENO:0087238', 'abnormal external female genitalia morphology'),
(601636, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003530', 'small clitoris', 0.56, 15.607147267911275, 2.9563495175689756, 'UPHENO:0069241', 'decreased size of the clitoris'),
(601637, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003527', 'small vulva', 0.4897959183673469, 11.684315128433736, 2.392264587963607, 'UPHENO:0087238', 'abnormal external female genitalia morphology'),
(601638, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003529', 'enlarged clitoris', 0.4716981132075472, 14.384754846574829, 2.604853493016923, 'UPHENO:0075153', 'abnormal size of clitoris'),
(601639, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003528', 'enlarged vulva', 0.43137254901960786, 11.684315128433736, 2.245059642971836, 'UPHENO:0087238', 'abnormal external female genitalia morphology'),
(601640, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003127', 'abnormal clitoris morphology', 0.4166666666666667, 13.732678149995134, 2.3920596207378777, 'UPHENO:0087115', 'abnormal clitoris morphology'),
(601641, 'HP:0040254', 'Decreased size of the clitoris', 'MP:0003513', 'small labia', 0.42105263157894735, 11.684315128433736, 2.2180422973930707, 'UPHENO:0087238', 'abnormal external female genitalia morphology'),
(601642, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0001329', 'retina hyperplasia', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601643, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0012671', 'retina spots', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601644, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0021107', 'retina fold', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601645, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0006188', 'calcified retina', 0.4375, 9.356059413574362, 2.023184616746278, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601646, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0011963', 'abnormal total retina thickness', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601647, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0001326', 'retina degeneration', 0.43548387096774194, 9.356059413574362, 2.01851751798877, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601648, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0003455', 'decreased susceptibility to induced retina damage', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601649, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0001325', 'abnormal retina morphology', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601650, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0020441', 'rhegmatogenous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601651, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0010707', 'decreased ventral retina size', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601652, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0020443', 'tractional retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601653, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0020038', 'retina macular degeneration', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601654, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0003099', 'retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601655, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0020442', 'serous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601656, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0006186', 'retina fibrosis', 0.4426229508196721, 9.356059413574362, 2.0349954854201657, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601657, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0006187', 'retina deposits', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601658, 'HP:0030643', 'Vitelliform-like retinal lesions', 'MP:0009392', 'retina gliosis', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(601659, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601660, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601661, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601662, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003470', 'abnormal summary potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601663, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601664, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601665, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601666, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601667, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601668, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601669, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601670, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601671, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601672, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601673, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601674, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601675, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601676, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601677, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601678, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601679, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003633', 'abnormal nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601680, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601681, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601682, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601683, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601684, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601685, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601686, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601687, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003488', 'decreased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601688, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601689, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601690, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000921', 'demyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601691, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601692, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601693, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601694, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601695, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601696, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601697, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601698, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601699, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601700, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601701, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601702, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003219', 'increased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601703, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601704, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601705, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003008', 'enhanced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601706, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601707, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601708, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601709, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601710, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601711, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001500', 'decreased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601712, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601713, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601714, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003463', 'abnormal single cell response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601715, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601716, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601717, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601718, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601719, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601720, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601721, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001900', 'impaired synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601722, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601723, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601724, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003482', 'increased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601725, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601726, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601727, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601728, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601729, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601730, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601731, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601732, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601733, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601734, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003487', 'increased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601735, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601736, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601737, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601738, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601739, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601740, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601741, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601742, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601743, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601744, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601745, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601746, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601747, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601748, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601749, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601750, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601751, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601752, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601753, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601754, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003486', 'abnormal channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601755, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601756, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601757, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601758, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003475', 'increased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601759, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601760, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601761, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601762, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601763, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601764, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601765, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601766, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601767, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601768, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601769, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601770, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601771, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601772, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601773, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601774, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601775, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601776, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601777, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601778, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601779, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601780, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012011', 'febrile seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601781, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020424', 'increased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601782, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011397', 'endoneurial edema', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601783, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601784, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601785, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009142', 'decreased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601786, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601787, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002923', 'increased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601788, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601789, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601790, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003477', 'abnormal nerve fiber response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601791, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601792, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601793, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601794, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601795, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601796, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601797, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601798, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601799, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601800, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601801, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012006', 'abnormal hippocampus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601802, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601803, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601804, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601805, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601806, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601807, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601808, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601809, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601810, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601811, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601812, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601813, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601814, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601815, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601816, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601817, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601818, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601819, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601820, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601821, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002193', 'minimal clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601822, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601823, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001473', 'reduced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601824, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601825, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013438', 'dysmyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601826, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601827, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601828, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003484', 'abnormal channel response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601829, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003485', 'abnormal channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601830, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601831, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003635', 'abnormal synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601832, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601833, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601834, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601835, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601836, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601837, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601838, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601839, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601840, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601841, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001496', 'audiogenic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601842, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601843, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008921', 'increased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601844, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601845, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601846, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601847, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601848, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601849, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601850, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601851, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601852, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601853, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601854, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601855, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601856, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601857, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601858, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601859, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601860, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601861, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601862, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601863, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601864, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601865, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601866, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601867, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601868, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601869, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601870, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601871, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601872, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601873, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601874, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601875, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601876, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601877, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601878, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601879, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006060', 'increased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601880, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601881, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601882, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601883, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601884, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601885, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601886, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601887, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601888, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601889, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601890, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601891, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601892, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014256', 'decreased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601893, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601894, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601895, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601896, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601897, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601898, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601899, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601900, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601901, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601902, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601903, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010149', 'abnormal synaptic dopamine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601904, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601905, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601906, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601907, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601908, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601909, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601910, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601911, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601912, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601913, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601914, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601915, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601916, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601917, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601918, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601919, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601920, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000920', 'abnormal myelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601921, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601922, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601923, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601924, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601925, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601926, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601927, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601928, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601929, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601930, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601931, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601932, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601933, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601934, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601935, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601936, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601937, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601938, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601939, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601940, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601941, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601942, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601943, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601944, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601945, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601946, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003889', 'enhanced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601947, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601948, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601949, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601950, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601951, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601952, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601953, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601954, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601955, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0010050', 'hypermyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(601956, 'HP:0031518', 'Absent posterior alpha rhythm', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(601957, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601958, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601959, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010177', 'acanthocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601960, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0009840', 'abnormal foam cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(601961, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010176', 'dacryocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601962, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.4444444444444444, 7.94655706237675, 1.8793092185252833, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(601963, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010696', 'increased siderocyte number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601964, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.42105263157894735, 7.94655706237675, 1.8291852730398854, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(601965, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010066', 'abnormal red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601966, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601967, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601968, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601969, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601970, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0001588', 'abnormal hemoglobin', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601971, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0005097', 'polychromatophilia', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601972, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.4146341463414634, 9.052558416233639, 1.9373951148697741, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(601973, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0002814', 'hyperchromasia', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601974, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.46153846153846156, 10.15319077934013, 2.164737409480221, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(601975, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0002447', 'abnormal erythrocyte morphology', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601976, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0002596', 'abnormal hematocrit', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601977, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0009568', 'abnormal red blood cell deformability', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601978, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012372', 'abnormal erythrocyte ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601979, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010068', 'decreased red blood cell distribution width', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601980, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0000358', 'abnormal cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(601981, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010175', 'leptocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601982, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601983, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010067', 'increased red blood cell distribution width', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601984, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0011171', 'increased number of Heinz bodies', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601985, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0002608', 'increased hematocrit', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601986, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601987, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0009547', 'elliptocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601988, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4594594594594595, 9.052558416233639, 2.0394321750545883, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(601989, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0010074', 'stomatocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(601990, 'HP:0004312', 'Abnormal reticulocyte morphology', 'MP:0002424', 'abnormal reticulocyte morphology', 0.43902439024390244, 10.15319077934013, 2.111278852006483, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(601991, 'HP:0009903', 'Conjunctival nodule', 'MP:0012164', 'abnormal conjunctiva goblet cell morphology', 0.4032258064516129, 12.104646927382092, 2.2092772617092864, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(601992, 'HP:0009903', 'Conjunctival nodule', 'MP:0001310', 'abnormal conjunctiva morphology', 0.43137254901960786, 12.104646927382092, 2.285084768678654, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(601993, 'HP:0009903', 'Conjunctival nodule', 'MP:0006164', 'ectropion', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(601994, 'HP:0009903', 'Conjunctival nodule', 'MP:0013754', 'abnormal ocular surface morphology', 0.41304347826086957, 9.656834392011628, 1.9971711159201337, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(601995, 'HP:0009903', 'Conjunctival nodule', 'MP:0030063', 'abnormal face size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(601996, 'HP:0009903', 'Conjunctival nodule', 'MP:0006225', 'ocular rupture', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(601997, 'HP:0009903', 'Conjunctival nodule', 'MP:0006191', 'conjunctival deposits', 0.4230769230769231, 12.104646927382092, 2.263006137192152, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(601998, 'HP:0009903', 'Conjunctival nodule', 'MP:0013744', 'abnormal conjunctival sac morphology', 0.40816326530612246, 12.062826751687464, 2.2189192765377475, 'UPHENO:0087131', 'abnormal conjunctival sac morphology'),
(601999, 'HP:0009903', 'Conjunctival nodule', 'MP:0031097', 'conjunctival chemosis', 0.4482758620689655, 12.906707549770184, 2.4053618133963246, 'UPHENO:0020997', 'abnormal conjunctiva morphology'),
(602000, 'HP:0009903', 'Conjunctival nodule', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.40816326530612246, 9.656834392011628, 1.9853375173919245, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(602001, 'HP:0009903', 'Conjunctival nodule', 'MP:0013402', 'abnormal bulbar conjunctiva morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(602002, 'HP:0009903', 'Conjunctival nodule', 'MP:0013461', 'abnormal conjunctiva fornix morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(602003, 'HP:0009903', 'Conjunctival nodule', 'MP:0006209', 'calcified intraocular region', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(602004, 'HP:0009903', 'Conjunctival nodule', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.4166666666666667, 9.656834392011628, 2.005911512672359, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(602005, 'HP:0009903', 'Conjunctival nodule', 'MP:0003671', 'abnormal eyelid aperture', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(602006, 'HP:0009903', 'Conjunctival nodule', 'MP:0013451', 'nasolacrimal duct obstruction', 0.41818181818181815, 9.656834392011628, 2.0095553149719803, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(602007, 'HP:0009903', 'Conjunctival nodule', 'MP:0004481', 'abnormal conjunctival epithelium morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(602008, 'HP:0009903', 'Conjunctival nodule', 'MP:0006166', 'eyelid retraction', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(602009, 'HP:0009903', 'Conjunctival nodule', 'MP:0005176', 'eyelids fail to open', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(602010, 'HP:0009903', 'Conjunctival nodule', 'MP:0002697', 'abnormal eye size', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(602011, 'HP:0009903', 'Conjunctival nodule', 'MP:0003664', 'ocular pterygium', 0.4230769230769231, 12.104646927382092, 2.263006137192152, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(602012, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602013, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602014, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602015, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602016, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602017, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602018, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602019, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(602020, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602021, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602022, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602023, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602024, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602025, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602026, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602027, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602028, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602029, 'HP:0030973', 'Postexertional symptom exacerbation', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(602030, 'HP:0001155', 'Abnormality of the hand', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602031, 'HP:0001155', 'Abnormality of the hand', 'MP:0003854', 'abnormal forelimb stylopod morphology', 0.4074074074074074, 7.310231061031986, 1.7257584663341918, 'UPHENO:0002880', 'abnormal arm'),
(602032, 'HP:0001155', 'Abnormality of the hand', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602033, 'HP:0001155', 'Abnormality of the hand', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602034, 'HP:0001155', 'Abnormality of the hand', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602035, 'HP:0001155', 'Abnormality of the hand', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.4230769230769231, 7.310231061031986, 1.7586330101197245, 'UPHENO:0002880', 'abnormal arm'),
(602036, 'HP:0001155', 'Abnormality of the hand', 'MP:0012531', 'delayed limb development', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(602037, 'HP:0001155', 'Abnormality of the hand', 'MP:0006279', 'abnormal limb development', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(602038, 'HP:0001155', 'Abnormality of the hand', 'MP:0002109', 'abnormal limb morphology', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(602039, 'HP:0001155', 'Abnormality of the hand', 'MP:0000550', 'abnormal forelimb morphology', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(602040, 'HP:0001155', 'Abnormality of the hand', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602041, 'HP:0001155', 'Abnormality of the hand', 'MP:0006280', 'abnormal digit development', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(602042, 'HP:0001155', 'Abnormality of the hand', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602043, 'HP:0001155', 'Abnormality of the hand', 'MP:0013133', 'pale limbs', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(602044, 'HP:0001155', 'Abnormality of the hand', 'MP:0000556', 'abnormal hindlimb morphology', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(602045, 'HP:0001155', 'Abnormality of the hand', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602046, 'HP:0001155', 'Abnormality of the hand', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602047, 'HP:0001155', 'Abnormality of the hand', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602048, 'HP:0001155', 'Abnormality of the hand', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(602049, 'HP:0001155', 'Abnormality of the hand', 'MP:0000572', 'abnormal autopod morphology', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(602050, 'HP:0000505', 'Visual impairment', 'MP:0011832', 'abnormal visual acuity', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602051, 'HP:0000505', 'Visual impairment', 'MP:0006147', 'monocular blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602052, 'HP:0000505', 'Visual impairment', 'MP:0020962', 'increased c-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602053, 'HP:0000505', 'Visual impairment', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602054, 'HP:0000505', 'Visual impairment', 'MP:0020978', 'abnormal FO-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602055, 'HP:0000505', 'Visual impairment', 'MP:0005258', 'ocular hypertension', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602056, 'HP:0000505', 'Visual impairment', 'MP:0012148', 'decreased a-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602057, 'HP:0000505', 'Visual impairment', 'MP:0012154', 'decreased b-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602058, 'HP:0000505', 'Visual impairment', 'MP:0012152', 'decreased a-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602059, 'HP:0000505', 'Visual impairment', 'MP:0012150', 'increased b-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602060, 'HP:0000505', 'Visual impairment', 'MP:0006152', 'tunnel vision', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602061, 'HP:0000505', 'Visual impairment', 'MP:0020860', 'abnormal cornea physiology', 0.46153846153846156, 8.795504987450572, 2.014811117787919, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602062, 'HP:0000505', 'Visual impairment', 'MP:0012145', 'increased a-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602063, 'HP:0000505', 'Visual impairment', 'MP:0012038', 'abnormal a-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602064, 'HP:0000505', 'Visual impairment', 'MP:0020974', 'abnormal FO-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602065, 'HP:0000505', 'Visual impairment', 'MP:0014179', 'abnormal blood-retina barrier function', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602066, 'HP:0000505', 'Visual impairment', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602067, 'HP:0000505', 'Visual impairment', 'MP:0001337', 'dry eyes', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602068, 'HP:0000505', 'Visual impairment', 'MP:0013468', 'chromodacryorrhea', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602069, 'HP:0000505', 'Visual impairment', 'MP:0020958', 'abnormal c-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602070, 'HP:0000505', 'Visual impairment', 'MP:0012040', 'abnormal c-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602071, 'HP:0000505', 'Visual impairment', 'MP:0020979', 'decreased FO-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602072, 'HP:0000505', 'Visual impairment', 'MP:0012034', 'abnormal a-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602073, 'HP:0000505', 'Visual impairment', 'MP:0012037', 'abnormal b-wave latency', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602074, 'HP:0000505', 'Visual impairment', 'MP:0006251', 'eyelid apraxia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602075, 'HP:0000505', 'Visual impairment', 'MP:0005260', 'ocular hypotension', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602076, 'HP:0000505', 'Visual impairment', 'MP:0003096', 'increased corneal light-scattering', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602077, 'HP:0000505', 'Visual impairment', 'MP:0006150', 'double vision', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602078, 'HP:0000505', 'Visual impairment', 'MP:0012033', 'abnormal ERG implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602079, 'HP:0000505', 'Visual impairment', 'MP:0013145', 'eye discharge', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602080, 'HP:0000505', 'Visual impairment', 'MP:0014157', 'alacrima', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602081, 'HP:0000505', 'Visual impairment', 'MP:0003011', 'delayed dark adaptation', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602082, 'HP:0000505', 'Visual impairment', 'MP:0014132', 'abnormal tear film physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602083, 'HP:0000505', 'Visual impairment', 'MP:0012153', 'increased b-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602084, 'HP:0000505', 'Visual impairment', 'MP:0012035', 'abnormal b-wave shape', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602085, 'HP:0000505', 'Visual impairment', 'MP:0020439', 'absent b-wave', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602086, 'HP:0000505', 'Visual impairment', 'MP:0031497', 'increased visual acuity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602087, 'HP:0000505', 'Visual impairment', 'MP:0003100', 'myopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602088, 'HP:0000505', 'Visual impairment', 'MP:0012147', 'increased a-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602089, 'HP:0000505', 'Visual impairment', 'MP:0006153', 'hypermetropia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602090, 'HP:0000505', 'Visual impairment', 'MP:0020959', 'decreased c-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602091, 'HP:0000505', 'Visual impairment', 'MP:0020980', 'increased FO-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602092, 'HP:0000505', 'Visual impairment', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602093, 'HP:0000505', 'Visual impairment', 'MP:0005257', 'abnormal intraocular pressure', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602094, 'HP:0000505', 'Visual impairment', 'MP:0004021', 'abnormal rod electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602095, 'HP:0000505', 'Visual impairment', 'MP:0008144', 'nyctalopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602096, 'HP:0000505', 'Visual impairment', 'MP:0020219', 'increased tear production', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602097, 'HP:0000505', 'Visual impairment', 'MP:0012143', 'decreased a-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602098, 'HP:0000505', 'Visual impairment', 'MP:0020218', 'abnormal tear production', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602099, 'HP:0000505', 'Visual impairment', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602100, 'HP:0000505', 'Visual impairment', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602101, 'HP:0000505', 'Visual impairment', 'MP:0012036', 'abnormal a-wave latency', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602102, 'HP:0000505', 'Visual impairment', 'MP:0012146', 'increased b-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602103, 'HP:0000505', 'Visual impairment', 'MP:0005253', 'abnormal eye physiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602104, 'HP:0000505', 'Visual impairment', 'MP:0020977', 'decreased FO-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602105, 'HP:0000505', 'Visual impairment', 'MP:0003101', 'high myopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602106, 'HP:0000505', 'Visual impairment', 'MP:0020861', 'abnormal corneal wound healing', 0.4186046511627907, 8.795504987450572, 1.9188119493770963, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602107, 'HP:0000505', 'Visual impairment', 'MP:0012032', 'abnormal ERG latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602108, 'HP:0000505', 'Visual impairment', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602109, 'HP:0000505', 'Visual impairment', 'MP:0020963', 'decreased c-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602110, 'HP:0000505', 'Visual impairment', 'MP:0006190', 'retina ischemia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602111, 'HP:0000505', 'Visual impairment', 'MP:0002001', 'blindness', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602112, 'HP:0000505', 'Visual impairment', 'MP:0001999', 'photosensitivity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602113, 'HP:0000505', 'Visual impairment', 'MP:0004022', 'abnormal cone electrophysiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602114, 'HP:0000505', 'Visual impairment', 'MP:0010748', 'abnormal visual evoked potential', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602115, 'HP:0000505', 'Visual impairment', 'MP:0010749', 'absent visual evoked potential', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602116, 'HP:0000505', 'Visual impairment', 'MP:0006145', 'legal blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602117, 'HP:0000505', 'Visual impairment', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602118, 'HP:0000505', 'Visual impairment', 'MP:0020976', 'increased FO-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602119, 'HP:0000505', 'Visual impairment', 'MP:0020960', 'increased c-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602120, 'HP:0000505', 'Visual impairment', 'MP:0020220', 'decreased tear production', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602121, 'HP:0000505', 'Visual impairment', 'MP:0001389', 'abnormal eye movement', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602122, 'HP:0000505', 'Visual impairment', 'MP:0012030', 'abnormal a-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602123, 'HP:0000505', 'Visual impairment', 'MP:0012151', 'increased a-wave latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602124, 'HP:0000505', 'Visual impairment', 'MP:0020961', 'abnormal c-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602125, 'HP:0000505', 'Visual impairment', 'MP:0012149', 'decreased b-wave implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602126, 'HP:0000505', 'Visual impairment', 'MP:0006149', 'decreased visual acuity', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602127, 'HP:0000505', 'Visual impairment', 'MP:0012039', 'abnormal b-wave implicit time', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602128, 'HP:0000505', 'Visual impairment', 'MP:0012144', 'decreased b-wave amplitude', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602129, 'HP:0000505', 'Visual impairment', 'MP:0008145', 'hemeralopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602130, 'HP:0000505', 'Visual impairment', 'MP:0020975', 'abnormal FO-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602131, 'HP:0000505', 'Visual impairment', 'MP:0006148', 'binocular blindness', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602132, 'HP:0000505', 'Visual impairment', 'MP:0005551', 'abnormal eye electrophysiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602133, 'HP:0000505', 'Visual impairment', 'MP:0002090', 'abnormal vision', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602134, 'HP:0000505', 'Visual impairment', 'MP:0012031', 'abnormal b-wave amplitude', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(602135, 'HP:0003097', 'Short femur', 'MP:0008158', 'increased diameter of femur', 0.4024390243902439, 11.359219754467691, 2.138081690633537, 'UPHENO:0020967', 'abnormal femur morphology'),
(602136, 'HP:0003097', 'Short femur', 'MP:0030826', 'decreased femur weight', 0.41379310344827586, 14.87018167374507, 2.4805601431166004, 'UPHENO:0069402', 'decreased size of the femur'),
(602137, 'HP:0003097', 'Short femur', 'MP:0030793', 'short femur neck', 0.43373493975903615, 10.700256672302757, 2.154315479025173, 'UPHENO:0087558', 'abnormal femur morphology'),
(602138, 'HP:0003097', 'Short femur', 'MP:0008152', 'decreased diameter of femur', 0.45569620253164556, 14.87018167374507, 2.6031299083375186, 'UPHENO:0069402', 'decreased size of the femur'),
(602139, 'HP:0003097', 'Short femur', 'MP:0004635', 'short metatarsal bones', 0.42168674698795183, 10.906707549770182, 2.1445778202274504, 'UPHENO:0046538', 'decreased length of long bone'),
(602140, 'HP:0003097', 'Short femur', 'MP:0030823', 'increased femur size', 0.4125, 11.359219754467691, 2.1646427300406694, 'UPHENO:0020967', 'abnormal femur morphology'),
(602141, 'HP:0003097', 'Short femur', 'MP:0030825', 'decreased femur size', 0.4675324675324675, 14.87018167374507, 2.6367200705767213, 'UPHENO:0069402', 'decreased size of the femur'),
(602142, 'HP:0003097', 'Short femur', 'MP:0002765', 'short fibula', 0.43373493975903615, 10.906707549770182, 2.174998883233965, 'UPHENO:0046538', 'decreased length of long bone'),
(602143, 'HP:0003097', 'Short femur', 'MP:0003109', 'short femur', 0.5189873417721519, 15.87018167374507, 2.8699169674919296, 'UPHENO:0046560', 'decreased length of femur'),
(602144, 'HP:0003097', 'Short femur', 'MP:0002764', 'short tibia', 0.43373493975903615, 10.906707549770182, 2.174998883233965, 'UPHENO:0046538', 'decreased length of long bone'),
(602145, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004969', 'pale kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602146, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602147, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011331', 'abnormal papillary duct morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602148, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602149, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011351', 'absent proximal convoluted tubule brush border', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602150, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602151, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602152, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.45714285714285713, 8.472720947690348, 1.9680558584047614, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(602153, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011289', 'abnormal nephron number', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602154, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011534', 'granular kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602155, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0002703', 'abnormal renal tubule morphology', 0.4864864864864865, 10.047451525800549, 2.2108707313929497, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602156, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011350', 'abnormal proximal convoluted tubule brush border morphology', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602157, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602158, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602159, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602160, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0002135', 'abnormal kidney morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602161, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004756', 'abnormal proximal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602162, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602163, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602164, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011352', 'proximal convoluted tubule brush border loss', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602165, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602166, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011341', 'abnormal loop of Henle descending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602167, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011342', 'abnormal loop of Henle ascending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602168, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602169, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011344', 'abnormal loop of Henle ascending limb thick segment morphology', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602170, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602171, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004755', 'abnormal loop of Henle morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602172, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0003881', 'abnormal nephron morphology', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602173, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011402', 'renal cast', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602174, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0011383', 'abnormal kidney capsule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602175, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0009860', 'nephrosclerosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602176, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602177, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0000527', 'abnormal kidney development', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(602178, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602179, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004757', 'abnormal distal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(602180, 'HP:0032625', 'Intratubular erythrocyte cast', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(602181, 'HP:0002266', 'Focal clonic seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602182, 'HP:0002266', 'Focal clonic seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602183, 'HP:0002266', 'Focal clonic seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602184, 'HP:0002266', 'Focal clonic seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602185, 'HP:0002266', 'Focal clonic seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602186, 'HP:0002266', 'Focal clonic seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602187, 'HP:0002266', 'Focal clonic seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602188, 'HP:0002266', 'Focal clonic seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602189, 'HP:0002266', 'Focal clonic seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602190, 'HP:0002266', 'Focal clonic seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602191, 'HP:0002266', 'Focal clonic seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602192, 'HP:0002266', 'Focal clonic seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602193, 'HP:0002266', 'Focal clonic seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602194, 'HP:0002266', 'Focal clonic seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602195, 'HP:0002266', 'Focal clonic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602196, 'HP:0002266', 'Focal clonic seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602197, 'HP:0002266', 'Focal clonic seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602198, 'HP:0002266', 'Focal clonic seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602199, 'HP:0002266', 'Focal clonic seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602200, 'HP:0002266', 'Focal clonic seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602201, 'HP:0002266', 'Focal clonic seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602202, 'HP:0002266', 'Focal clonic seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602203, 'HP:0002266', 'Focal clonic seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602204, 'HP:0002266', 'Focal clonic seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602205, 'HP:0002266', 'Focal clonic seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602206, 'HP:0002266', 'Focal clonic seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602207, 'HP:0002266', 'Focal clonic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602208, 'HP:0002266', 'Focal clonic seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602209, 'HP:0002266', 'Focal clonic seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602210, 'HP:0002266', 'Focal clonic seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602211, 'HP:0002266', 'Focal clonic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602212, 'HP:0002266', 'Focal clonic seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602213, 'HP:0002266', 'Focal clonic seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602214, 'HP:0002266', 'Focal clonic seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602215, 'HP:0002266', 'Focal clonic seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602216, 'HP:0002266', 'Focal clonic seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602217, 'HP:0002266', 'Focal clonic seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602218, 'HP:0002266', 'Focal clonic seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602219, 'HP:0002266', 'Focal clonic seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602220, 'HP:0002266', 'Focal clonic seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602221, 'HP:0002266', 'Focal clonic seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602222, 'HP:0002266', 'Focal clonic seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602223, 'HP:0002266', 'Focal clonic seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602224, 'HP:0002266', 'Focal clonic seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602225, 'HP:0002266', 'Focal clonic seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602226, 'HP:0002266', 'Focal clonic seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602227, 'HP:0002266', 'Focal clonic seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602228, 'HP:0002266', 'Focal clonic seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602229, 'HP:0002266', 'Focal clonic seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602230, 'HP:0002266', 'Focal clonic seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602231, 'HP:0002266', 'Focal clonic seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602232, 'HP:0002266', 'Focal clonic seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602233, 'HP:0002266', 'Focal clonic seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602234, 'HP:0002266', 'Focal clonic seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602235, 'HP:0002266', 'Focal clonic seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602236, 'HP:0002266', 'Focal clonic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602237, 'HP:0002266', 'Focal clonic seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602238, 'HP:0002266', 'Focal clonic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602239, 'HP:0002266', 'Focal clonic seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602240, 'HP:0002266', 'Focal clonic seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602241, 'HP:0002266', 'Focal clonic seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602242, 'HP:0002266', 'Focal clonic seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602243, 'HP:0002266', 'Focal clonic seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602244, 'HP:0002266', 'Focal clonic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602245, 'HP:0002266', 'Focal clonic seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602246, 'HP:0002266', 'Focal clonic seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602247, 'HP:0002266', 'Focal clonic seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602248, 'HP:0002266', 'Focal clonic seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602249, 'HP:0002266', 'Focal clonic seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602250, 'HP:0002266', 'Focal clonic seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602251, 'HP:0002266', 'Focal clonic seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602252, 'HP:0002266', 'Focal clonic seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602253, 'HP:0002266', 'Focal clonic seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602254, 'HP:0002266', 'Focal clonic seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602255, 'HP:0002266', 'Focal clonic seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602256, 'HP:0002266', 'Focal clonic seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602257, 'HP:0002266', 'Focal clonic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602258, 'HP:0002266', 'Focal clonic seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602259, 'HP:0002266', 'Focal clonic seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602260, 'HP:0002266', 'Focal clonic seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602261, 'HP:0002266', 'Focal clonic seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602262, 'HP:0002266', 'Focal clonic seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602263, 'HP:0002266', 'Focal clonic seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602264, 'HP:0002266', 'Focal clonic seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602265, 'HP:0002266', 'Focal clonic seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602266, 'HP:0002266', 'Focal clonic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602267, 'HP:0002266', 'Focal clonic seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602268, 'HP:0002266', 'Focal clonic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602269, 'HP:0002266', 'Focal clonic seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602270, 'HP:0002266', 'Focal clonic seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602271, 'HP:0002266', 'Focal clonic seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602272, 'HP:0002266', 'Focal clonic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602273, 'HP:0002266', 'Focal clonic seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602274, 'HP:0002266', 'Focal clonic seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602275, 'HP:0002266', 'Focal clonic seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602276, 'HP:0002266', 'Focal clonic seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602277, 'HP:0002266', 'Focal clonic seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602278, 'HP:0002266', 'Focal clonic seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602279, 'HP:0002266', 'Focal clonic seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602280, 'HP:0002266', 'Focal clonic seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602281, 'HP:0002266', 'Focal clonic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602282, 'HP:0002266', 'Focal clonic seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602283, 'HP:0002266', 'Focal clonic seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602284, 'HP:0002266', 'Focal clonic seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602285, 'HP:0002266', 'Focal clonic seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602286, 'HP:0002266', 'Focal clonic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602287, 'HP:0002266', 'Focal clonic seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602288, 'HP:0002266', 'Focal clonic seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602289, 'HP:0002266', 'Focal clonic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602290, 'HP:0002266', 'Focal clonic seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602291, 'HP:0002266', 'Focal clonic seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602292, 'HP:0002266', 'Focal clonic seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602293, 'HP:0002266', 'Focal clonic seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602294, 'HP:0002266', 'Focal clonic seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602295, 'HP:0002266', 'Focal clonic seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602296, 'HP:0002266', 'Focal clonic seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602297, 'HP:0002266', 'Focal clonic seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602298, 'HP:0002266', 'Focal clonic seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602299, 'HP:0002266', 'Focal clonic seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602300, 'HP:0002266', 'Focal clonic seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602301, 'HP:0002266', 'Focal clonic seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602302, 'HP:0002266', 'Focal clonic seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602303, 'HP:0002266', 'Focal clonic seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602304, 'HP:0002266', 'Focal clonic seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602305, 'HP:0002266', 'Focal clonic seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602306, 'HP:0002266', 'Focal clonic seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602307, 'HP:0002266', 'Focal clonic seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602308, 'HP:0002266', 'Focal clonic seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602309, 'HP:0002266', 'Focal clonic seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602310, 'HP:0002266', 'Focal clonic seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602311, 'HP:0002266', 'Focal clonic seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602312, 'HP:0002266', 'Focal clonic seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602313, 'HP:0002266', 'Focal clonic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602314, 'HP:0002266', 'Focal clonic seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602315, 'HP:0002266', 'Focal clonic seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602316, 'HP:0002266', 'Focal clonic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602317, 'HP:0002266', 'Focal clonic seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602318, 'HP:0002266', 'Focal clonic seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602319, 'HP:0002266', 'Focal clonic seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602320, 'HP:0002266', 'Focal clonic seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602321, 'HP:0002266', 'Focal clonic seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602322, 'HP:0002266', 'Focal clonic seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602323, 'HP:0002266', 'Focal clonic seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602324, 'HP:0002266', 'Focal clonic seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602325, 'HP:0002266', 'Focal clonic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602326, 'HP:0002266', 'Focal clonic seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602327, 'HP:0002266', 'Focal clonic seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602328, 'HP:0002266', 'Focal clonic seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602329, 'HP:0002266', 'Focal clonic seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602330, 'HP:0002266', 'Focal clonic seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602331, 'HP:0002266', 'Focal clonic seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602332, 'HP:0002266', 'Focal clonic seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602333, 'HP:0002266', 'Focal clonic seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602334, 'HP:0002266', 'Focal clonic seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602335, 'HP:0002266', 'Focal clonic seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602336, 'HP:0002266', 'Focal clonic seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602337, 'HP:0002266', 'Focal clonic seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602338, 'HP:0002266', 'Focal clonic seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602339, 'HP:0002266', 'Focal clonic seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602340, 'HP:0002266', 'Focal clonic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602341, 'HP:0002266', 'Focal clonic seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602342, 'HP:0002266', 'Focal clonic seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602343, 'HP:0002266', 'Focal clonic seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602344, 'HP:0002266', 'Focal clonic seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602345, 'HP:0002266', 'Focal clonic seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602346, 'HP:0002266', 'Focal clonic seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602347, 'HP:0002266', 'Focal clonic seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602348, 'HP:0002266', 'Focal clonic seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602349, 'HP:0002266', 'Focal clonic seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602350, 'HP:0002266', 'Focal clonic seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602351, 'HP:0002266', 'Focal clonic seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602352, 'HP:0002266', 'Focal clonic seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602353, 'HP:0002266', 'Focal clonic seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602354, 'HP:0002266', 'Focal clonic seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602355, 'HP:0002266', 'Focal clonic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602356, 'HP:0002266', 'Focal clonic seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602357, 'HP:0002266', 'Focal clonic seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602358, 'HP:0002266', 'Focal clonic seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602359, 'HP:0002266', 'Focal clonic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602360, 'HP:0002266', 'Focal clonic seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602361, 'HP:0002266', 'Focal clonic seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(602362, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003769', 'abnormal lip morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602363, 'HP:0000157', 'Abnormality of the tongue', 'MP:0013262', 'abnormal mouth floor morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602364, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003772', 'lip pits', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602365, 'HP:0000157', 'Abnormality of the tongue', 'MP:0013818', 'abnormal oral cavity morphology', 0.4444444444444444, 9.27922043240247, 2.030787524571848, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(602366, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003751', 'oral leukoplakia', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602367, 'HP:0000157', 'Abnormality of the tongue', 'MP:0030606', 'abnormal gingival sulcus moprhology', 0.425531914893617, 9.27922043240247, 1.987109569027385, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(602368, 'HP:0000157', 'Abnormality of the tongue', 'MP:0013131', 'pale lips', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602369, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003755', 'abnormal palate morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602370, 'HP:0000157', 'Abnormality of the tongue', 'MP:0000762', 'abnormal tongue morphology', 0.40816326530612246, 11.032238431854042, 2.1220166026639005, 'UPHENO:0003041', 'abnormal tongue'),
(602371, 'HP:0000157', 'Abnormality of the tongue', 'MP:0000452', 'abnormal mouth morphology', 0.4318181818181818, 7.503859459499253, 1.8000841503719018, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602372, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003785', 'lip mucosal nodules', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602373, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003770', 'lip ulcer', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602374, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003747', 'mouth mucosal ulcer', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602375, 'HP:0000157', 'Abnormality of the tongue', 'MP:0013492', 'oral erythroplakia', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602376, 'HP:0000157', 'Abnormality of the tongue', 'MP:0003745', 'abnormal oral mucosa morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602377, 'HP:0000157', 'Abnormality of the tongue', 'MP:0021164', 'oral cleft', 0.4222222222222222, 7.503859459499253, 1.7799708470177307, 'UPHENO:0076800', 'abnormal mouth morphology'),
(602378, 'HP:0012161', 'External carotid artery dissection', 'MP:0006133', 'calcified artery', 0.42857142857142855, 8.259895016664046, 1.8814768154675023, 'UPHENO:0086797', 'abnormal artery morphology'),
(602379, 'HP:0012161', 'External carotid artery dissection', 'MP:0000265', 'blood vessel atresia', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(602380, 'HP:0012161', 'External carotid artery dissection', 'MP:0006134', 'artery occlusion', 0.4090909090909091, 8.259895016664046, 1.838218692474474, 'UPHENO:0086797', 'abnormal artery morphology'),
(602381, 'HP:0012161', 'External carotid artery dissection', 'MP:0011655', 'abnormal systemic artery morphology', 0.41025641025641024, 9.101997348968142, 1.9323956009448564, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(602382, 'HP:0012161', 'External carotid artery dissection', 'MP:0012562', 'blood vessel degeneration', 0.4146341463414634, 6.970522647367627, 1.7000637362890585, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(602383, 'HP:0005988', 'Congenital muscular torticollis', 'MP:0000733', 'abnormal muscle development', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(602384, 'HP:0005988', 'Congenital muscular torticollis', 'MP:0000752', 'dystrophic muscle', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(602385, 'HP:0005988', 'Congenital muscular torticollis', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(602386, 'HP:0001683', 'Ectopia cordis', 'MP:0010592', 'abnormal atrioventricular septum morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602387, 'HP:0001683', 'Ectopia cordis', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602388, 'HP:0001683', 'Ectopia cordis', 'MP:0010551', 'abnormal coronary vessel morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602389, 'HP:0001683', 'Ectopia cordis', 'MP:0000285', 'abnormal heart valve morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602390, 'HP:0001683', 'Ectopia cordis', 'MP:0012688', 'abnormal heart ventricles weight', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602391, 'HP:0001683', 'Ectopia cordis', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.46153846153846156, 7.506484928906078, 1.8613252014758086, 'UPHENO:0076810', 'abnormal heart morphology'),
(602392, 'HP:0001683', 'Ectopia cordis', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.46153846153846156, 7.506484928906078, 1.8613252014758086, 'UPHENO:0076810', 'abnormal heart morphology'),
(602393, 'HP:0001683', 'Ectopia cordis', 'MP:0010444', 'total anomalous pulmonary venous connection, infracardiac', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602394, 'HP:0001683', 'Ectopia cordis', 'MP:0010650', 'abnormal aorticopulmonary septum morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602395, 'HP:0001683', 'Ectopia cordis', 'MP:0000644', 'dextrocardia', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602396, 'HP:0001683', 'Ectopia cordis', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602397, 'HP:0001683', 'Ectopia cordis', 'MP:0012501', 'abnormal pericardial cavity morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602398, 'HP:0001683', 'Ectopia cordis', 'MP:0010545', 'abnormal heart layer morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602399, 'HP:0001683', 'Ectopia cordis', 'MP:0010478', 'intracranial aneurysm', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602400, 'HP:0001683', 'Ectopia cordis', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.46153846153846156, 7.506484928906078, 1.8613252014758086, 'UPHENO:0076810', 'abnormal heart morphology'),
(602401, 'HP:0001683', 'Ectopia cordis', 'MP:0002839', 'increased susceptibility to dystrophic cardiac calcinosis', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602402, 'HP:0001683', 'Ectopia cordis', 'MP:0006126', 'abnormal cardiac outflow tract development', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602403, 'HP:0001683', 'Ectopia cordis', 'MP:0002838', 'decreased susceptibility to dystrophic cardiac calcinosis', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602404, 'HP:0001683', 'Ectopia cordis', 'MP:0010440', 'anomalous pulmonary venous connection', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602405, 'HP:0001683', 'Ectopia cordis', 'MP:0006065', 'abnormal heart position or orientation', 0.4482758620689655, 7.506484928906078, 1.8343870918137941, 'UPHENO:0076810', 'abnormal heart morphology'),
(602406, 'HP:0001683', 'Ectopia cordis', 'MP:0010454', 'abnormal truncus arteriosus septation', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602407, 'HP:0001683', 'Ectopia cordis', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4074074074074074, 7.347404004220494, 1.7301406926993756, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(602408, 'HP:0001683', 'Ectopia cordis', 'MP:0011665', 'd-loop transposition of the great arteries', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602409, 'HP:0001683', 'Ectopia cordis', 'MP:0012700', 'abnormal endocardial heart tube morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602410, 'HP:0001683', 'Ectopia cordis', 'MP:0010430', 'total anomalous pulmonary venous connection, supracardiac', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602411, 'HP:0001683', 'Ectopia cordis', 'MP:0000292', 'distended pericardium', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602412, 'HP:0001683', 'Ectopia cordis', 'MP:0003920', 'abnormal heart right ventricle morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602413, 'HP:0001683', 'Ectopia cordis', 'MP:0011668', 'double outlet right ventricle, Taussig bing type', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602414, 'HP:0001683', 'Ectopia cordis', 'MP:0011667', 'double outlet right ventricle with atrioventricular septal defect', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602415, 'HP:0001683', 'Ectopia cordis', 'MP:0003921', 'abnormal heart left ventricle morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602416, 'HP:0001683', 'Ectopia cordis', 'MP:0014044', 'absent cardiac outflow tract', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602417, 'HP:0001683', 'Ectopia cordis', 'MP:0010433', 'double inlet heart left ventricle', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602418, 'HP:0001683', 'Ectopia cordis', 'MP:0010421', 'ventricular aneurysm', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602419, 'HP:0001683', 'Ectopia cordis', 'MP:0012687', 'abnormal heart atrium weight', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602420, 'HP:0001683', 'Ectopia cordis', 'MP:0005294', 'abnormal heart ventricle morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602421, 'HP:0001683', 'Ectopia cordis', 'MP:0010224', 'abnormal heart ventricle outflow tract morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602422, 'HP:0001683', 'Ectopia cordis', 'MP:0013332', 'peliosis', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602423, 'HP:0001683', 'Ectopia cordis', 'MP:0002746', 'abnormal semilunar valve morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602424, 'HP:0001683', 'Ectopia cordis', 'MP:0004032', 'abnormal interventricular groove morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602425, 'HP:0001683', 'Ectopia cordis', 'MP:0011669', 'double outlet right ventricle, doubly committed ventricular septal defect', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602426, 'HP:0001683', 'Ectopia cordis', 'MP:0011254', 'superior-inferior ventricles', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(602427, 'HP:0001683', 'Ectopia cordis', 'MP:0010409', 'cor triatriatum', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602428, 'HP:0001683', 'Ectopia cordis', 'MP:0011511', 'biventricular, ambiguous atrioventricular connection', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602429, 'HP:0001683', 'Ectopia cordis', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602430, 'HP:0001683', 'Ectopia cordis', 'MP:0012082', 'delayed heart development', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602431, 'HP:0001683', 'Ectopia cordis', 'MP:0003141', 'cardiac fibrosis', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602432, 'HP:0001683', 'Ectopia cordis', 'MP:0010443', 'total anomalous pulmonary venous connection, intracardiac', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602433, 'HP:0001683', 'Ectopia cordis', 'MP:0010546', 'abnormal subendocardium layer morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602434, 'HP:0001683', 'Ectopia cordis', 'MP:0000284', 'double outlet right ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602435, 'HP:0001683', 'Ectopia cordis', 'MP:0006113', 'abnormal heart septum morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602436, 'HP:0001683', 'Ectopia cordis', 'MP:0000288', 'abnormal pericardium morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602437, 'HP:0001683', 'Ectopia cordis', 'MP:0010489', 'abnormal heart atrium auricular region morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602438, 'HP:0001683', 'Ectopia cordis', 'MP:0011510', 'biventricular, discordant atrioventricular connection', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602439, 'HP:0001683', 'Ectopia cordis', 'MP:0011670', 'double outlet right ventricle, noncommitted ventricular septal defect', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602440, 'HP:0001683', 'Ectopia cordis', 'MP:0011666', 'double outlet right ventricle, ventricular defect committed to aorta', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602441, 'HP:0001683', 'Ectopia cordis', 'MP:0005406', 'abnormal heart size', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602442, 'HP:0001683', 'Ectopia cordis', 'MP:0010445', 'total anomalous pulmonary venous connection, mixed', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602443, 'HP:0001683', 'Ectopia cordis', 'MP:0000266', 'abnormal heart morphology', 0.48, 7.506484928906078, 1.8981867046934338, 'UPHENO:0076810', 'abnormal heart morphology'),
(602444, 'HP:0001683', 'Ectopia cordis', 'MP:0000650', 'mesocardia', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602445, 'HP:0001683', 'Ectopia cordis', 'MP:0012515', 'abnormal heart apex morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602446, 'HP:0001683', 'Ectopia cordis', 'MP:0003105', 'abnormal heart atrium morphology', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602447, 'HP:0001683', 'Ectopia cordis', 'MP:0004110', 'transposition of great arteries', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602448, 'HP:0001683', 'Ectopia cordis', 'MP:0003279', 'aneurysm', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602449, 'HP:0001683', 'Ectopia cordis', 'MP:0010441', 'total anomalous pulmonary venous connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602450, 'HP:0001683', 'Ectopia cordis', 'MP:0003057', 'abnormal epicardium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602451, 'HP:0001683', 'Ectopia cordis', 'MP:0010427', 'double outlet left ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602452, 'HP:0001683', 'Ectopia cordis', 'MP:0003922', 'abnormal heart right atrium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602453, 'HP:0001683', 'Ectopia cordis', 'MP:0003228', 'abnormal sinus venosus morphology', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602454, 'HP:0001683', 'Ectopia cordis', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4583333333333333, 5.978701727774094, 1.6553665128594512, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602455, 'HP:0001683', 'Ectopia cordis', 'MP:0011648', 'thick heart valve cusps', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602456, 'HP:0001683', 'Ectopia cordis', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602457, 'HP:0001683', 'Ectopia cordis', 'MP:0009382', 'abnormal cardiac jelly morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602458, 'HP:0001683', 'Ectopia cordis', 'MP:0003923', 'abnormal heart left atrium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602459, 'HP:0001683', 'Ectopia cordis', 'MP:0000358', 'abnormal cell morphology', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(602460, 'HP:0001683', 'Ectopia cordis', 'MP:0010426', 'abnormal heart and great artery attachment', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602461, 'HP:0001683', 'Ectopia cordis', 'MP:0003974', 'abnormal endocardium morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(602462, 'HP:0001683', 'Ectopia cordis', 'MP:0010434', 'double inlet heart right ventricle', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602463, 'HP:0001683', 'Ectopia cordis', 'MP:0011660', 'ectopia cordis', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(602464, 'HP:0001683', 'Ectopia cordis', 'MP:0010442', 'partial anomalous pulmonary venous connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(602465, 'HP:0001683', 'Ectopia cordis', 'MP:0005608', 'cardiac interstitial fibrosis', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(602466, 'HP:0001683', 'Ectopia cordis', 'MP:0002925', 'abnormal cardiovascular development', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(602467, 'HP:0001683', 'Ectopia cordis', 'MP:0000267', 'abnormal heart development', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(602468, 'HP:0002972', 'Reduced delayed hypersensitivity', 'MP:0001828', 'abnormal T cell activation', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(602469, 'HP:0002972', 'Reduced delayed hypersensitivity', 'MP:0003945', 'abnormal lymphocyte physiology', 0.40425531914893614, 9.680357114865052, 1.9782153206730166, 'UPHENO:0085566', 'abnormality of lymphocyte physiology'),
(602470, 'HP:0002972', 'Reduced delayed hypersensitivity', 'MP:0002444', 'abnormal T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(602471, 'HP:0002972', 'Reduced delayed hypersensitivity', 'MP:0001819', 'abnormal immune cell physiology', 0.41025641025641024, 7.733703155395898, 1.7812358896343274, 'UPHENO:0085578', 'abnormality of cell physiology'),
(602472, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602473, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602474, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602475, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602476, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602477, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602478, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602479, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602480, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602481, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602482, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602483, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602484, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602485, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602486, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602487, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602488, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602489, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602490, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602491, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602492, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602493, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602494, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602495, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602496, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602497, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602498, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602499, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602500, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602501, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602502, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602503, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602504, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602505, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602506, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602507, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602508, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602509, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602510, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602511, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602512, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602513, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602514, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602515, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602516, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602517, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602518, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602519, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602520, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602521, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602522, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602523, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602524, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602525, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602526, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602527, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602528, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602529, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602530, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602531, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602532, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602533, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602534, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602535, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602536, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602537, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602538, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602539, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602540, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602541, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602542, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602543, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602544, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602545, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602546, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602547, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602548, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602549, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602550, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602551, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602552, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602553, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602554, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602555, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602556, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602557, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602558, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602559, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602560, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602561, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602562, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602563, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602564, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602565, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602566, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602567, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602568, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602569, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602570, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602571, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602572, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602573, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602574, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602575, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602576, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602577, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602578, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602579, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602580, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602581, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602582, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602583, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602584, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602585, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602586, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602587, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602588, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602589, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602590, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602591, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602592, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602593, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602594, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602595, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602596, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602597, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602598, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602599, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602600, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602601, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602602, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602603, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602604, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602605, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602606, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602607, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602608, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602609, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602610, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602611, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602612, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602613, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602614, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602615, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602616, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602617, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602618, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602619, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602620, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602621, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602622, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602623, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602624, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602625, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602626, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602627, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602628, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602629, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602630, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602631, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602632, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602633, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602634, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602635, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602636, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602637, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602638, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602639, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602640, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602641, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602642, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602643, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602644, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602645, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602646, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602647, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602648, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602649, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602650, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602651, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602652, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602653, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602654, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602655, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602656, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602657, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602658, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602659, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602660, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602661, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602662, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602663, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602664, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602665, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602666, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602667, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602668, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602669, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602670, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602671, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602672, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602673, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602674, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602675, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602676, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602677, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602678, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602679, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602680, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602681, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602682, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602683, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602684, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602685, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602686, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602687, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602688, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602689, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602690, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602691, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602692, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602693, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602694, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602695, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602696, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602697, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602698, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602699, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602700, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602701, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602702, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602703, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602704, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602705, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602706, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602707, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602708, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602709, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602710, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602711, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602712, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602713, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602714, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602715, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602716, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602717, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602718, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602719, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602720, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602721, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602722, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602723, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602724, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602725, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602726, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602727, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602728, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602729, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602730, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602731, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602732, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602733, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602734, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602735, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602736, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602737, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602738, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602739, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602740, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602741, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602742, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602743, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602744, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602745, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602746, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602747, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602748, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602749, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602750, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602751, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602752, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602753, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602754, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602755, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602756, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602757, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602758, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602759, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602760, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602761, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602762, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602763, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602764, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602765, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602766, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602767, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602768, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602769, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602770, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602771, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602772, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602773, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602774, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602775, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602776, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602777, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602778, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602779, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602780, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602781, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602782, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602783, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602784, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602785, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602786, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602787, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602788, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602789, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602790, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602791, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602792, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602793, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602794, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602795, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602796, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602797, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602798, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602799, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602800, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602801, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602802, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602803, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602804, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602805, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602806, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602807, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602808, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602809, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602810, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602811, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602812, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602813, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602814, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602815, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602816, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602817, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602818, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602819, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602820, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602821, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602822, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602823, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602824, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602825, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602826, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602827, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602828, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602829, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602830, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602831, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602832, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602833, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602834, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602835, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602836, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602837, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602838, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602839, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602840, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602841, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602842, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602843, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602844, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602845, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602846, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602847, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602848, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602849, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602850, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602851, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602852, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602853, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602854, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602855, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602856, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602857, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602858, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602859, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602860, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602861, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602862, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602863, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602864, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602865, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602866, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602867, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602868, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602869, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602870, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602871, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602872, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602873, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602874, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602875, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602876, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602877, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602878, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602879, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602880, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602881, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602882, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602883, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602884, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602885, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602886, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602887, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602888, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602889, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602890, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602891, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602892, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602893, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602894, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602895, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602896, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602897, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602898, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602899, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602900, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602901, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602902, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602903, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602904, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602905, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602906, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602907, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602908, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602909, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602910, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602911, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602912, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602913, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602914, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602915, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602916, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602917, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602918, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602919, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602920, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602921, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602922, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602923, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602924, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602925, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602926, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602927, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602928, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602929, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602930, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602931, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602932, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602933, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602934, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602935, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602936, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602937, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602938, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602939, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602940, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602941, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602942, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602943, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602944, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602945, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602946, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602947, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602948, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602949, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602950, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602951, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602952, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602953, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602954, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602955, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602956, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602957, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602958, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602959, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602960, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602961, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602962, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602963, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602964, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602965, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602966, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602967, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602968, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602969, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602970, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602971, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602972, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602973, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602974, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602975, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602976, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602977, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602978, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602979, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602980, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602981, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602982, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602983, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602984, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602985, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602986, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602987, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602988, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602989, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602990, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602991, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602992, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602993, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602994, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602995, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602996, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(602997, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602998, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(602999, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603000, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603001, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603002, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603003, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603004, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603005, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603006, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603007, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603008, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603009, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603010, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603011, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603012, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603013, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603014, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603015, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603016, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603017, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603018, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603019, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603020, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603021, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603022, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603023, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603024, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603025, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603026, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603027, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603028, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603029, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603030, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603031, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603032, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603033, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603034, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603035, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603036, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603037, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603038, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603039, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603040, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603041, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603042, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603043, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603044, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603045, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603046, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603047, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603048, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603049, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603050, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603051, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603052, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603053, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603054, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603055, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603056, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603057, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603058, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603059, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603060, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603061, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603062, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603063, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603064, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603065, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603066, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603067, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603068, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603069, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603070, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603071, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603072, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603073, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603074, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603075, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603076, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603077, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603078, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603079, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603080, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603081, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603082, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603083, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603084, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603085, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603086, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603087, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603088, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603089, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603090, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603091, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603092, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603093, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603094, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603095, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603096, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603097, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603098, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603099, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603100, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603101, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603102, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603103, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603104, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603105, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603106, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603107, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603108, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603109, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603110, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603111, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603112, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603113, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603114, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603115, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603116, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603117, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603118, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603119, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603120, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603121, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603122, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603123, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603124, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603125, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603126, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603127, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603128, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603129, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603130, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603131, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603132, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603133, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603134, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603135, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603136, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603137, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603138, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603139, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603140, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603141, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603142, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603143, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603144, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603145, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603146, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603147, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603148, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603149, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603150, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603151, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603152, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603153, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603154, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603155, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603156, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603157, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603158, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603159, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603160, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603161, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603162, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603163, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603164, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603165, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603166, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603167, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603168, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603169, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603170, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603171, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603172, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603173, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603174, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603175, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603176, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603177, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603178, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603179, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603180, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603181, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603182, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603183, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603184, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603185, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603186, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603187, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603188, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603189, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603190, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603191, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603192, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603193, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603194, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603195, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603196, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603197, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603198, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603199, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603200, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603201, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603202, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603203, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603204, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603205, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603206, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603207, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603208, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603209, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603210, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603211, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603212, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603213, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603214, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603215, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603216, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603217, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603218, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603219, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603220, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(603221, 'HP:0033563', 'Anti-tissue transglutaminase antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(603222, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030682', 'hydroxyprolinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603223, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030618', 'tryptophanuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603224, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020402', 'ornithinuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603225, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030616', 'hyperglycinuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603226, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0011470', 'increased urine creatinine level', 0.40298507462686567, 9.50911518495075, 1.9575575323455603, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(603227, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0013730', 'glutathionuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603228, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603229, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030612', 'organic aciduria', 0.43636363636363634, 10.430558536187952, 2.133428333025214, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(603230, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.5517241379310345, 10.47786425096631, 2.404348273695554, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603231, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020406', 'hyperthreoninuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603232, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030614', 'methylmalonic aciduria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603233, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030617', 'hyperglutaminuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603234, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603235, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0002931', 'glutaricadicuria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603236, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0011654', 'histidinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603237, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0003311', 'aminoaciduria', 0.48484848484848486, 10.47786425096631, 2.253924711814731, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603238, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603239, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030620', 'valinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603240, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020400', 'cystinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603241, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020404', 'prolinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603242, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0011517', 'hyperoxaluria', 0.49230769230769234, 10.47786425096631, 2.271196418125586, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603243, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0011765', 'oroticaciduria', 0.5245901639344263, 10.47786425096631, 2.344479585131225, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603244, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020405', 'taurinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603245, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0030689', 'cystathioninuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603246, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020403', 'lysinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603247, 'HP:0033220', '2-ethylhydracylic aciduria', 'MP:0020401', 'argininuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(603248, 'HP:0031492', 'Epithelial neoplasm', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603249, 'HP:0031492', 'Epithelial neoplasm', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603250, 'HP:0031492', 'Epithelial neoplasm', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603251, 'HP:0031492', 'Epithelial neoplasm', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603252, 'HP:0031492', 'Epithelial neoplasm', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603253, 'HP:0031492', 'Epithelial neoplasm', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603254, 'HP:0031492', 'Epithelial neoplasm', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603255, 'HP:0031492', 'Epithelial neoplasm', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603256, 'HP:0031492', 'Epithelial neoplasm', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603257, 'HP:0031492', 'Epithelial neoplasm', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603258, 'HP:0031492', 'Epithelial neoplasm', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603259, 'HP:0031492', 'Epithelial neoplasm', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603260, 'HP:0031492', 'Epithelial neoplasm', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603261, 'HP:0031492', 'Epithelial neoplasm', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603262, 'HP:0031492', 'Epithelial neoplasm', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(603263, 'HP:0031492', 'Epithelial neoplasm', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603264, 'HP:0031492', 'Epithelial neoplasm', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603265, 'HP:0031492', 'Epithelial neoplasm', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(603266, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030313', 'abnormal face development', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(603267, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030226', 'middle ear polyps', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(603268, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003330', 'abnormal auditory tube morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603269, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030161', 'absent auditory bulla', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(603270, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000018', 'small ears', 0.4146341463414634, 9.987538624383228, 2.034987604771472, 'UPHENO:0002901', 'abnormal external ear'),
(603271, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000020', 'scaly ears', 0.5, 9.987538624383228, 2.234674319043295, 'UPHENO:0002901', 'abnormal external ear'),
(603272, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000023', 'abnormal ear position', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603273, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030324', 'abnormal anterior head development', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(603274, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000022', 'abnormal ear shape', 0.4146341463414634, 9.987538624383228, 2.034987604771472, 'UPHENO:0002901', 'abnormal external ear'),
(603275, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(603276, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0002859', 'abnormal inner ear canal fusion', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(603277, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0012176', 'abnormal head development', 0.4666666666666667, 4.6730878730104815, 1.4767445076038797, 'UPHENO:0087907', 'abnormal head morphology'),
(603278, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0002729', 'abnormal inner ear canal morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603279, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(603280, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030078', 'synotia', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(603281, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013097', 'ear wound', 0.4722222222222222, 9.987538624383228, 2.171713075831272, 'UPHENO:0002901', 'abnormal external ear'),
(603282, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603283, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013101', 'ear open laceration', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603284, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(603285, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003737', 'ossification of pinnae', 0.5, 9.987538624383228, 2.234674319043295, 'UPHENO:0002901', 'abnormal external ear'),
(603286, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0011238', 'abnormal inner ear development', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603287, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003677', 'abnormal ear lobe morphology', 0.4857142857142857, 9.987538624383228, 2.202519055306024, 'UPHENO:0002901', 'abnormal external ear'),
(603288, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0031285', 'external auditory canal stenosis', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(603289, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603290, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0002102', 'abnormal ear morphology', 0.5161290322580645, 7.8051695233081215, 2.0071060242735457, 'UPHENO:0076730', 'abnormal ear morphology'),
(603291, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000049', 'abnormal middle ear morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(603292, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030095', 'abnormal midface morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(603293, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003935', 'abnormal craniofacial development', 0.42857142857142855, 4.656469875639396, 1.4126676702970866, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(603294, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(603295, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013100', 'ear open incision', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603296, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030178', 'abnormal scalp morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(603297, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0020290', 'floppy ears', 0.5, 9.987538624383228, 2.234674319043295, 'UPHENO:0002901', 'abnormal external ear'),
(603298, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013103', 'ear closed contusion', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603299, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013114', 'greasy head/neck', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(603300, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0020305', 'abnormal horn pigmentation', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(603301, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(603302, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000052', 'early ear unfolding', 0.425, 9.987538624383228, 2.060267923199037, 'UPHENO:0002901', 'abnormal external ear'),
(603303, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0004426', 'abnormal cochlear labyrinth morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(603304, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030092', 'abnormal outer ear helix morphology', 0.4857142857142857, 9.987538624383228, 2.202519055306024, 'UPHENO:0002901', 'abnormal external ear'),
(603305, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030160', 'abnormal auditory bulla morphology', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
(603306, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003712', 'raised ear position', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(603307, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030413', 'tympanic membrane retraction', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(603308, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000428', 'abnormal craniofacial morphology', 0.4444444444444444, 4.656469875639396, 1.4385903402118487, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(603309, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000024', 'lowered ear position', 0.4146341463414634, 9.987538624383228, 2.034987604771472, 'UPHENO:0002901', 'abnormal external ear'),
(603310, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013102', 'ear open puncture', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603311, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0020304', 'abnormal horn morphology', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(603312, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013099', 'ear open avulsion', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603313, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003683', 'prominent ear lobes', 0.40476190476190477, 9.987538624383228, 2.010615616543463, 'UPHENO:0002901', 'abnormal external ear'),
(603314, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003743', 'abnormal facial morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(603315, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0006287', 'inner ear cyst', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(603316, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003681', 'protruding ear lobes', 0.4358974358974359, 9.987538624383228, 2.086514432563373, 'UPHENO:0002901', 'abnormal external ear'),
(603317, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000017', 'big ears', 0.4146341463414634, 9.987538624383228, 2.034987604771472, 'UPHENO:0002901', 'abnormal external ear'),
(603318, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003682', 'linear crease in ear lobe', 0.4722222222222222, 9.987538624383228, 2.171713075831272, 'UPHENO:0002901', 'abnormal external ear'),
(603319, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000026', 'abnormal inner ear morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(603320, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0006033', 'abnormal external auditory canal morphology', 0.4722222222222222, 9.987538624383228, 2.171713075831272, 'UPHENO:0002901', 'abnormal external ear'),
(603321, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0013098', 'ear open abrasion', 0.4473684210526316, 9.987538624383228, 2.1137902886976505, 'UPHENO:0002901', 'abnormal external ear'),
(603322, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0000432', 'abnormal head morphology', 0.4827586206896552, 4.6730878730104815, 1.5019898321680125, 'UPHENO:0087907', 'abnormal head morphology'),
(603323, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0004427', 'abnormal vestibular labyrinth morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(603324, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0002177', 'abnormal outer ear morphology', 0.5151515151515151, 9.987538624383228, 2.268280329894279, 'UPHENO:0002901', 'abnormal external ear'),
(603325, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0003938', 'abnormal ear development', 0.5, 7.8051695233081215, 1.975496079888305, 'UPHENO:0076730', 'abnormal ear morphology'),
(603326, 'HP:0000356', 'Abnormality of the outer ear', 'MP:0030228', 'absent tubotympanic recess', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(603327, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002313', 'abnormal tidal volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603328, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0010857', 'pulmonary necrosis', 0.4318181818181818, 9.915985363358194, 2.0692759048858225, 'UPHENO:0019970', 'abnormal lung morphology'),
(603329, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002133', 'abnormal respiratory system physiology', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(603330, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0010937', 'increased total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(603331, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002308', 'abnormal residual volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603332, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002311', 'abnormal inspiratory capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603333, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002337', 'abnormal whole-body plethysmography', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603334, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0004881', 'abnormal lung size', 0.4473684210526316, 9.915985363358194, 2.1062048132094278, 'UPHENO:0019970', 'abnormal lung morphology'),
(603335, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0003828', 'pulmonary edema', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(603336, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0006050', 'pulmonary fibrosis', 0.4473684210526316, 9.915985363358194, 2.1062048132094278, 'UPHENO:0019970', 'abnormal lung morphology'),
(603337, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002309', 'abnormal vital capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603338, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0003641', 'small lung', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(603339, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0005629', 'abnormal lung weight', 0.4146341463414634, 9.915985363358194, 2.0276849178978646, 'UPHENO:0019970', 'abnormal lung morphology'),
(603340, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0011162', 'abnormal wet-to-dry lung weight ratio', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(603341, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0005586', 'decreased tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(603342, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0001958', 'emphysema', 0.40476190476190477, 9.150450616995217, 1.9245139181530309, 'UPHENO:0086908', 'abnormal lung morphology'),
(603343, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0010938', 'decreased total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(603344, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603345, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0005585', 'increased tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(603346, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002304', 'abnormal total lung capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(603347, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0001942', 'abnormal lung volume', 0.4878048780487805, 9.915985363358194, 2.1993330877578403, 'UPHENO:0019970', 'abnormal lung morphology'),
(603348, 'HP:0032978', 'Lipid-laden macrophages in bronchoalveolar fluid', 'MP:0002306', 'abnormal functional residual capacity', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(603349, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020066', 'abnormal neocortex size', 0.4117647058823529, 8.700256672302757, 1.8927383944358827, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(603350, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020573', 'abnormal corpus callosum size', 0.4107142857142857, 10.963291078136551, 2.1219755569361904, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603351, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020141', 'decreased brain external capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603352, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020569', 'abnormal premotor cortex size', 0.4117647058823529, 8.700256672302757, 1.8927383944358827, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(603353, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0012137', 'abnormal forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(603354, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0000791', 'delaminated cerebral cortex', 0.42857142857142855, 8.700256672302757, 1.9309793968312805, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(603355, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0008228', 'increased anterior commissure size', 0.41379310344827586, 12.30946671927059, 2.256894422776627, 'UPHENO:0002589', 'abnormal anterior commissure'),
(603356, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020140', 'increased brain external capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603357, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0008226', 'decreased anterior commissure size', 0.41379310344827586, 12.30946671927059, 2.256894422776627, 'UPHENO:0002589', 'abnormal anterior commissure'),
(603358, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0012462', 'decreased brain internal capsule size', 0.4339622641509434, 10.963291078136551, 2.1812048548483416, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603359, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0020139', 'abnormal brain external capsule morphology', 0.40425531914893614, 10.963291078136551, 2.1052241528432964, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603360, 'HP:0030301', 'Abnormality of the anterior commissure', 'MP:0012461', 'increased brain internal capsule size', 0.4339622641509434, 10.963291078136551, 2.1812048548483416, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(603361, 'HP:0010766', 'Ectopic calcification', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603362, 'HP:0010766', 'Ectopic calcification', 'MP:0031169', 'abnormal joint physiology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603363, 'HP:0010766', 'Ectopic calcification', 'MP:0004945', 'abnormal bone resorption', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603364, 'HP:0010766', 'Ectopic calcification', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603365, 'HP:0010766', 'Ectopic calcification', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603366, 'HP:0010766', 'Ectopic calcification', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603367, 'HP:0010766', 'Ectopic calcification', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603368, 'HP:0010766', 'Ectopic calcification', 'MP:0002114', 'abnormal axial skeleton morphology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603369, 'HP:0010766', 'Ectopic calcification', 'MP:0010924', 'abnormal osteoid morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603370, 'HP:0010766', 'Ectopic calcification', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603371, 'HP:0010766', 'Ectopic calcification', 'MP:0005504', 'abnormal ligament morphology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603372, 'HP:0010766', 'Ectopic calcification', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603373, 'HP:0010766', 'Ectopic calcification', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603374, 'HP:0010766', 'Ectopic calcification', 'MP:0013941', 'abnormal enthesis morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603375, 'HP:0010766', 'Ectopic calcification', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603376, 'HP:0010766', 'Ectopic calcification', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603377, 'HP:0010766', 'Ectopic calcification', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603378, 'HP:0010766', 'Ectopic calcification', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603379, 'HP:0010766', 'Ectopic calcification', 'MP:0002113', 'abnormal skeleton development', 0.47619047619047616, 4.401455821078525, 1.4477331740934605, 'UPHENO:0002964', 'abnormal skeletal system'),
(603380, 'HP:0010766', 'Ectopic calcification', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603381, 'HP:0010766', 'Ectopic calcification', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603382, 'HP:0010766', 'Ectopic calcification', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603383, 'HP:0010766', 'Ectopic calcification', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603384, 'HP:0010766', 'Ectopic calcification', 'MP:0009918', 'abnormal stylohyoid ligament morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603385, 'HP:0010766', 'Ectopic calcification', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603386, 'HP:0010766', 'Ectopic calcification', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603387, 'HP:0010766', 'Ectopic calcification', 'MP:0010971', 'abnormal periosteum morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603388, 'HP:0010766', 'Ectopic calcification', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603389, 'HP:0010766', 'Ectopic calcification', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603390, 'HP:0010766', 'Ectopic calcification', 'MP:0010874', 'abnormal bone volume', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603391, 'HP:0010766', 'Ectopic calcification', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603392, 'HP:0010766', 'Ectopic calcification', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603393, 'HP:0010766', 'Ectopic calcification', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603394, 'HP:0010766', 'Ectopic calcification', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603395, 'HP:0010766', 'Ectopic calcification', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603396, 'HP:0010766', 'Ectopic calcification', 'MP:0010124', 'decreased bone mineral content', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603397, 'HP:0010766', 'Ectopic calcification', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603398, 'HP:0010766', 'Ectopic calcification', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603399, 'HP:0010766', 'Ectopic calcification', 'MP:0010122', 'abnormal bone mineral content', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603400, 'HP:0010766', 'Ectopic calcification', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603401, 'HP:0010766', 'Ectopic calcification', 'MP:0031348', 'bone fibrous dysplasia', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603402, 'HP:0010766', 'Ectopic calcification', 'MP:0020039', 'increased bone ossification', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603403, 'HP:0010766', 'Ectopic calcification', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603404, 'HP:0010766', 'Ectopic calcification', 'MP:0002896', 'abnormal bone mineralization', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603405, 'HP:0010766', 'Ectopic calcification', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603406, 'HP:0010766', 'Ectopic calcification', 'MP:0030818', 'abnormal girdle joint morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603407, 'HP:0010766', 'Ectopic calcification', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603408, 'HP:0010766', 'Ectopic calcification', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603409, 'HP:0010766', 'Ectopic calcification', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603410, 'HP:0010766', 'Ectopic calcification', 'MP:0014024', 'increased subchondral bone mineral content', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603411, 'HP:0010766', 'Ectopic calcification', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603412, 'HP:0010766', 'Ectopic calcification', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603413, 'HP:0010766', 'Ectopic calcification', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603414, 'HP:0010766', 'Ectopic calcification', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603415, 'HP:0010766', 'Ectopic calcification', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603416, 'HP:0010766', 'Ectopic calcification', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603417, 'HP:0010766', 'Ectopic calcification', 'MP:0014025', 'decreased subchondral bone mineral content', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603418, 'HP:0010766', 'Ectopic calcification', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603419, 'HP:0010766', 'Ectopic calcification', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603420, 'HP:0010766', 'Ectopic calcification', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603421, 'HP:0010766', 'Ectopic calcification', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603422, 'HP:0010766', 'Ectopic calcification', 'MP:0009807', 'abnormal pelvic ligament morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603423, 'HP:0010766', 'Ectopic calcification', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603424, 'HP:0010766', 'Ectopic calcification', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603425, 'HP:0010766', 'Ectopic calcification', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603426, 'HP:0010766', 'Ectopic calcification', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603427, 'HP:0010766', 'Ectopic calcification', 'MP:0031349', 'monostotic fibrous dysplasia', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603428, 'HP:0010766', 'Ectopic calcification', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603429, 'HP:0010766', 'Ectopic calcification', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603430, 'HP:0010766', 'Ectopic calcification', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603431, 'HP:0010766', 'Ectopic calcification', 'MP:0003795', 'abnormal bone structure', 0.47619047619047616, 4.401455821078525, 1.4477331740934605, 'UPHENO:0002964', 'abnormal skeletal system'),
(603432, 'HP:0010766', 'Ectopic calcification', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603433, 'HP:0010766', 'Ectopic calcification', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603434, 'HP:0010766', 'Ectopic calcification', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603435, 'HP:0010766', 'Ectopic calcification', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603436, 'HP:0010766', 'Ectopic calcification', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603437, 'HP:0010766', 'Ectopic calcification', 'MP:0004149', 'increased bone strength', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603438, 'HP:0010766', 'Ectopic calcification', 'MP:0000163', 'abnormal cartilage morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603439, 'HP:0010766', 'Ectopic calcification', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603440, 'HP:0010766', 'Ectopic calcification', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603441, 'HP:0010766', 'Ectopic calcification', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603442, 'HP:0010766', 'Ectopic calcification', 'MP:0010123', 'increased bone mineral content', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603443, 'HP:0010766', 'Ectopic calcification', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603444, 'HP:0010766', 'Ectopic calcification', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603445, 'HP:0010766', 'Ectopic calcification', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603446, 'HP:0010766', 'Ectopic calcification', 'MP:0001533', 'abnormal skeleton physiology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603447, 'HP:0010766', 'Ectopic calcification', 'MP:0030878', 'abnormal fibrous joint morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603448, 'HP:0010766', 'Ectopic calcification', 'MP:0004624', 'abnormal thoracic cage morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603449, 'HP:0010766', 'Ectopic calcification', 'MP:0000566', 'synostosis', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603450, 'HP:0010766', 'Ectopic calcification', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603451, 'HP:0010766', 'Ectopic calcification', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603452, 'HP:0010766', 'Ectopic calcification', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603453, 'HP:0010766', 'Ectopic calcification', 'MP:0001542', 'abnormal bone strength', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603454, 'HP:0010766', 'Ectopic calcification', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603455, 'HP:0010766', 'Ectopic calcification', 'MP:0030222', 'hyperostosis', 0.47619047619047616, 4.401455821078525, 1.4477331740934605, 'UPHENO:0002964', 'abnormal skeletal system'),
(603456, 'HP:0010766', 'Ectopic calcification', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603457, 'HP:0010766', 'Ectopic calcification', 'MP:0009877', 'exostosis', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603458, 'HP:0010766', 'Ectopic calcification', 'MP:0003723', 'abnormal long bone morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603459, 'HP:0010766', 'Ectopic calcification', 'MP:0013304', 'osteophytes', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603460, 'HP:0010766', 'Ectopic calcification', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603461, 'HP:0010766', 'Ectopic calcification', 'MP:0020040', 'decreased bone ossification', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603462, 'HP:0010766', 'Ectopic calcification', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603463, 'HP:0010766', 'Ectopic calcification', 'MP:0002932', 'abnormal joint morphology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603464, 'HP:0010766', 'Ectopic calcification', 'MP:0005508', 'abnormal skeleton morphology', 0.5, 4.401455821078525, 1.4834850557182107, 'UPHENO:0002964', 'abnormal skeletal system'),
(603465, 'HP:0010766', 'Ectopic calcification', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603466, 'HP:0010766', 'Ectopic calcification', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603467, 'HP:0010766', 'Ectopic calcification', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603468, 'HP:0010766', 'Ectopic calcification', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603469, 'HP:0010766', 'Ectopic calcification', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603470, 'HP:0010766', 'Ectopic calcification', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603471, 'HP:0010766', 'Ectopic calcification', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603472, 'HP:0010766', 'Ectopic calcification', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603473, 'HP:0010766', 'Ectopic calcification', 'MP:0002998', 'abnormal bone remodeling', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603474, 'HP:0010766', 'Ectopic calcification', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603475, 'HP:0010766', 'Ectopic calcification', 'MP:0003797', 'abnormal compact bone morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603476, 'HP:0010766', 'Ectopic calcification', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603477, 'HP:0010766', 'Ectopic calcification', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603478, 'HP:0010766', 'Ectopic calcification', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603479, 'HP:0010766', 'Ectopic calcification', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603480, 'HP:0010766', 'Ectopic calcification', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603481, 'HP:0010766', 'Ectopic calcification', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603482, 'HP:0010766', 'Ectopic calcification', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603483, 'HP:0010766', 'Ectopic calcification', 'MP:0005422', 'osteosclerosis', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603484, 'HP:0010766', 'Ectopic calcification', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603485, 'HP:0010766', 'Ectopic calcification', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603486, 'HP:0010766', 'Ectopic calcification', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603487, 'HP:0010766', 'Ectopic calcification', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603488, 'HP:0010766', 'Ectopic calcification', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603489, 'HP:0010766', 'Ectopic calcification', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603490, 'HP:0010766', 'Ectopic calcification', 'MP:0013639', 'decreased bone stiffness', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603491, 'HP:0010766', 'Ectopic calcification', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603492, 'HP:0010766', 'Ectopic calcification', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603493, 'HP:0010766', 'Ectopic calcification', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603494, 'HP:0010766', 'Ectopic calcification', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603495, 'HP:0010766', 'Ectopic calcification', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603496, 'HP:0010766', 'Ectopic calcification', 'MP:0030804', 'abnormal synovial joint morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603497, 'HP:0010766', 'Ectopic calcification', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603498, 'HP:0010766', 'Ectopic calcification', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603499, 'HP:0010766', 'Ectopic calcification', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603500, 'HP:0010766', 'Ectopic calcification', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603501, 'HP:0010766', 'Ectopic calcification', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603502, 'HP:0010766', 'Ectopic calcification', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603503, 'HP:0010766', 'Ectopic calcification', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603504, 'HP:0010766', 'Ectopic calcification', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.45454545454545453, 4.401455821078525, 1.414447502332227, 'UPHENO:0002964', 'abnormal skeletal system'),
(603505, 'HP:0010766', 'Ectopic calcification', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603506, 'HP:0010766', 'Ectopic calcification', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603507, 'HP:0010766', 'Ectopic calcification', 'MP:0008271', 'abnormal bone ossification', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603508, 'HP:0010766', 'Ectopic calcification', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603509, 'HP:0010766', 'Ectopic calcification', 'MP:0000130', 'abnormal trabecular bone morphology', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603510, 'HP:0010766', 'Ectopic calcification', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603511, 'HP:0010766', 'Ectopic calcification', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603512, 'HP:0010766', 'Ectopic calcification', 'MP:0013636', 'abnormal bone stiffness', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603513, 'HP:0010766', 'Ectopic calcification', 'MP:0013640', 'increased bone stiffness', 0.4166666666666667, 4.401455821078525, 1.3542303812311203, 'UPHENO:0002964', 'abnormal skeletal system'),
(603514, 'HP:0010766', 'Ectopic calcification', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603515, 'HP:0010766', 'Ectopic calcification', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603516, 'HP:0010766', 'Ectopic calcification', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(603517, 'HP:0010766', 'Ectopic calcification', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.43478260869565216, 4.401455821078525, 1.383356947409881, 'UPHENO:0002964', 'abnormal skeletal system'),
(603518, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001191', 'abnormal skin condition', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603519, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0031103', 'skin rash', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603520, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0009932', 'skin fibrosis', 0.4117647058823529, 7.4735768925632104, 1.7542392057685403, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603521, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001208', 'blistering', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603522, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0002095', 'abnormal skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603523, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001213', 'abnormal skin cell number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603524, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001212', 'skin lesions', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603525, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0003652', 'abnormal skin turgor', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603526, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0005421', 'loose skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603527, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603528, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0011239', 'abnormal skin coloration', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603529, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001193', 'psoriasis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603530, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001201', 'translucent skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603531, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0013406', 'abnormal epidermal immune compartment', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603532, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0002060', 'abnormal skin morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603533, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0002897', 'blotchy skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603534, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0003853', 'dry skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603535, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0008816', 'petechiae', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603536, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001216', 'abnormal epidermal layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603537, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001198', 'tight skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603538, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.42424242424242425, 7.4735768925632104, 1.7806202230299364, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603539, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0003653', 'decreased skin turgor', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603540, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0009441', 'delayed skin barrier formation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603541, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0003196', 'calcified skin', 0.4117647058823529, 7.4735768925632104, 1.7542392057685403, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603542, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603543, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001195', 'flaky skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603544, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0011160', 'dermal-epidermal separation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603545, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0009827', 'skin detachment', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603546, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0009931', 'abnormal skin appearance', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603547, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0003941', 'abnormal skin development', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603548, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001243', 'abnormal dermal layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603549, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(603550, 'HP:0007385', 'Aplasia cutis congenita of scalp', 'MP:0001210', 'skin ridges', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
